Brandy Farrar, PhD, MS
Brandy Farrar, PhD, MS has over 18 years of experience as a qualitative methodologist whose primary expertise is in identifying evidence-based practices for improving health. Dr. Farrar routinely deploys a variety of methodologies to engage interested parties in designing, implementing and evaluating policies and programs. Examples of Dr. Farrar’s current and recent work include using human […]
Sarita Edwards, MHA
Sarita Edwards is the CEO & President at the E.WE Foundation, a global healthcare advocacy organization for families impacted by Trisomy 18 and other rare diseases. Sarita began her advocacy and public policy efforts after receiving a rare genetic diagnosis for her unborn son. Sarita is recognized as a world’s top patient expert and social […]
Bridget Doherty, MPH, MS
Bridget Doherty, MPH, MS, is a strategic policy, research, and communications professional with extensive experience in pharmaceuticals, medical devices, and healthcare publishing. Currently serving as the Director of Access and Policy Research at Johnson & Johnson Innovative Medicine, she develops and executes impactful policy research and scientific engagement plans aimed at developing an evidence-based understanding […]
Jason Spangler, MD, MPH, FACPM
For nearly two decades, Dr. Spangler, Center for Innovation & Value Research Chief Executive Officer, has worked in the professional health policy and public health sector with pharmaceutical and non-profit organizations. Dr. Spangler joins the Center from his most recent role as Executive Medical Director and Director and Head of Global HTA Policy Strategy & […]
Ilisa Halpern Paul, MPP
Ilisa Halpern Paul is a senior policy advisor at Venable LLP in the firm’s Washington, DC office. Ilisa co-leads the firm’s Federal Health Policy team, drawing on more than 30 years of recorded success in helping established and start-up healthcare companies, health and hospital systems, provider associations, and nonprofit patient advocacy organizations advance their legislative, […]